by PEPID Newsroom | Oct 31, 2018 | Alerts
Yesterday the U.S. Food and Drug Administration approved Xofluza (balorxavir marhboxil), a new influenza treatment for acute uncomplicated influenza in people age 12 and older who have been symptomatic for no more than 2 days. This new drug, developed by Genentech,...
by PEPID Newsroom | Oct 22, 2018 | Alerts
The CDC is baffled by the cause of polio-like disease, Acute Flaccid Myelitis (AFM), affecting children in the United States. A reoccurring outbreak of AFM has been affecting Americans 21 and under since 2014. The CDC has recorded spikes in cases of Acute Flaccid...
by PEPID Newsroom | Oct 22, 2018 | Alerts
Toxic dinoflagellates algal blooms known as “red tides” are spreading across the Florida coastline, killing thousands of marine animals, and causing respiratory and gastrointestinal distress in residents. People in effected areas are warned not to swim in the water,...
by Anna Tan | Oct 17, 2018 | Press & Media
For Immediate Release: October 17, 2018 — Phoenix, AZ STATEMENT: Web-based point-of-care solutions provider, PEPID, LLC, released a new feature on their IV Compatibility Checker that adds an extra layer of assurance to, not only safe, but effective IV drug...
by Anna Tan | Oct 15, 2018 | Pharmacy, Primary Care
Getting a Bigger Slice of the P.I.E.: The Pharmacist’s Duties in Clinical Pharmacogenomics (PGx) Ninety percent of Americans live within 5 miles of a community pharmacy, with local patients averaging 35 drugstore visits annually. Compared to the average frequency of 4...
by Anna Tan | Oct 8, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care
Pharmacogenomics (PGx) is rapidly evolving from being a “luxury” diagnostic test to the healthcare standard millions of patients and providers have been waiting for. Although PGx is a relatively new field, the R&D support and buzz behind it is growing...
by PEPID Newsroom | Oct 2, 2018 | Alerts
The FDA approved cemiplimab-rwlc (Libtayo) for treatment of locally advanced, or metastatic, cutaneous squamous cell carcinoma (CSCC). This is the first drug treatment approved for advanced CSCC, the second most common cancer in the U.S. Please see the FDA website for...
by pepidwpblog | Oct 1, 2018 | Press & Media
For Immediate Release: October 1, 2018 — Phoenix, AZ STATEMENT: PEPID, LLC announces its participation in American Pharmacists Month, a celebration in support of pharmacists across the country. The American Pharmacists Association (APhA) officially launched American...
by Anna Tan | Oct 1, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care
While medical R&D has been making great strides in precision medicine and pharmacogenetics – ultimately tailoring diagnostics and treatments to match individuals on a submolecular level – healthcare providers need to remember that their relationships with their...
by pepidwpblog | Sep 18, 2018 | Press & Media
For Immediate Release: September 18, 2018 — Phoenix, AZ STATEMENT: PEPID, LLC announces it is an official National Health IT Week (NHIT Week) partner. NHIT Week 2018 is presented by the Healthcare Information and Management Systems Society (HIMSS) to promote the use...
